Scientists test copycat drug in healthy volunteers
NCT ID NCT07246252
Summary
This study aimed to see if a new manufacturing version of the drug Omalizumab (called Process-Changed CMAB007) behaves similarly to the original drug (Xolair) in the body. It involved 114 healthy Chinese male volunteers who received a single injection. Researchers monitored the participants for over 3 months to compare how the drugs were processed, their safety, and whether they triggered an immune response.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS (HV) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Xuhui Central Hospital, Shanghai
Shanghai, China
Conditions
Explore the condition pages connected to this study.